BHCFX Holdings Information

BHCFX is a mutual fund with a total of 44 individual holdings. The top holdings are Eli Lilly and Company stock at 11.42%, argenx SE at 6.78%, Thermo Fisher Scientific at 5.23%, Insmed at 4.62%, and Usd at 4.27%.

Total Holdings

Top 10 Percentage

50.03%

Asset Class

Equity

Fund Category

Health

Assets

139.68M

Forward PE Ratio

26.69

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	11.42%	15,300
2	ARGX	argenx SE	6.78%	11,600
3	TMO	Thermo Fisher Scientific Inc.	5.23%	13,000
4	INSM	Insmed Incorporated	4.62%	38,200
5	n/a	Usd	4.27%	6,146,090
6	AZN	AstraZeneca PLC	3.96%	62,000
7	ABBV	AbbVie Inc.	3.94%	24,800
8	MTD	Mettler-Toledo International Inc.	3.39%	3,500
9	ISRG	Intuitive Surgical, Inc.	3.31%	8,400
10	BSX	Boston Scientific Corporation	3.11%	47,000
11	DHR	Danaher Corporation	3.10%	19,500
12	RDNT	RadNet, Inc.	2.97%	60,000
13	MCK	McKesson Corporation	2.85%	5,000
14	IDXX	IDEXX Laboratories, Inc.	2.82%	6,000
15	PEN	Penumbra, Inc.	2.81%	13,000
16	TEVA	Teva Pharmaceutical Industries Limited	2.60%	120,000
17	ABVX	ABIVAX Société Anonyme	2.34%	25,000
18	GILD	Gilead Sciences, Inc.	2.26%	26,500
19	IONS	Ionis Pharmaceuticals, Inc.	1.98%	36,000
20	EW	Edwards Lifesciences Corporation	1.97%	33,300
21	SYK	Stryker Corporation	1.95%	8,000
22	ROIV	Roivant Sciences Ltd.	1.88%	125,000
23	VRTX	Vertex Pharmaceuticals Incorporated	1.64%	5,200
24	UNH	UnitedHealth Group Incorporated	1.38%	6,000
25	EHC	Encompass Health Corporation	1.29%	17,500

Showing 25 of 44 holdings

Subscribe to see the full list

Activate Now

As of Dec 31, 2025